BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 22, 2000
View Archived Issues
MDS Nordion to manufacture Altropane diagnostic agent
Read More
Lynx Therapeutics enters partnership to identify diabetes-associated SNPs
Read More
Dendreon describes therapeutic cancer vaccine technology
Read More
NIH offers V1 knockout mice for S. pneumoniae vaccine screening
Read More
Peptide vaccines available for licensing from NIH
Read More
cDNA clones of tick-borne flavivirus available for licensing from NIH
Read More
Suplatast tosilate improves asthma symptoms in a double-blind trial
Read More
Malaria incidence and resistance controlled by artesunate-mefloquine treatment
Read More
Research links development of type 1 diabetes with inflammation
Read More
Mechanism of resistance to ABL tyrosine kinase inhibitor STI-571 explored
Read More
Potent, selective human A2B adenosine receptor antagonists reported
Read More
Orally active dual NK1/NK2 antagonist synthesized by Schering-Plough
Read More
Selective ICAM-1 and E-selectin inhibitors on human endothelial cells explored
Read More
Wyeth-Ayerst recommends that certain lots of Norplant not be implanted
Read More
Psoriasis therapy proceeds to clinical trials
Read More
Interneuron enrolls first patients in phase I/II study of PRO-2000 Gel
Read More
Syntheses and SAR presented for DuPont Pharmaceuticals' CRF receptor antagonists
Read More
Orphan Medical's Antizol sNDA accepted for filing
Read More
FDA approves Santen's levofloxacin eyedrops
Read More
Inex's Onco TCS given fast track status
Read More
New series of PARP inhibitors claimed by Guilford
Read More
Elan and Biogen establish Antegren collaboration agreement
Read More
Novel compounds useful for neurological disorders claimed by AstraZeneca
Read More
Seven key sessions and symposia from XXII ESC Congress available to Daily Essentials readers
Read More